Our expertise
Drug discovery & optimization
We have profound experience in drug discovery and optimization, and provide advice through project initiation, medicinal chemistry optimization and clinical candidate selection.
We guide the optimization of the in vitro and in vivo profiles of drug candidates, from hits discovered in screening campaigns to Ph I clinical trial readiness.
Clinical development
We bring over 19 years of global clinical development experience across large pharmaceutical organizations and small biotech companies, with deep expertise in designing scientifically rigorous, operationally feasible, and globally aligned development strategies.
Our background spans neurology, neuroimmunology, and rare diseases
Imaging agents
We provide advice on the whole process of discovery and development of nuclear imaging agents, as disease biomarkers or to accelerate drug clinical trials.
PET and SPECT imaging agents are radiolabeled with short‑lived isotopes. They enable clinical imaging studies to determine drug biodistribution, target engagement, or to monitor disease progression.
